On the public citation graph
Female sex, good performance status, and bevacizumab‐induced hypertension associated with survival benefit in Asian patients with recurrent glioblastoma treated with bevacizumab
0 signed · 44 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/14651858.cd008218.pub3openalex-snapshot
Antiangiogenic therapy for high-grade glioma
inferredcites →https://doi.org/10.1002/cncr.26381openalex-snapshot
Bevacizumab and daily temozolomide for recurrent glioblastoma
inferredcites →https://doi.org/10.1002/cncr.29234openalex-snapshot
Bevacizumab‐induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab
inferredcites →https://doi.org/10.1007/s00401-007-0243-4openalex-snapshot
The 2007 WHO Classification of Tumours of the Central Nervous System
inferredcites →https://doi.org/10.1007/s00401-016-1545-1openalex-snapshot
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
inferredcites →https://doi.org/10.1007/s11060-011-0722-2openalex-snapshot
Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma
inferredcites →https://doi.org/10.1007/s11060-013-1102-xopenalex-snapshot
Differential molecular genetic analysis in glioblastoma multiforme of long- and short-term survivors: a clinical study in Chinese patients
inferredcites →https://doi.org/10.1007/s11060-013-1170-yopenalex-snapshot
Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimen
inferredcites →https://doi.org/10.1016/j.jocn.2009.12.009openalex-snapshot
Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme
inferredcites →https://doi.org/10.1038/sj.bjc.6605412openalex-snapshot
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
inferredcites →https://doi.org/10.1056/nejmoa1308345openalex-snapshot
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
inferredcites →https://doi.org/10.1093/annonc/mdq328openalex-snapshot
Proteinuria and favourable clinical response in a patient receiving paclitaxel + bevacizumab for metastatic breast cancer
inferredcites →https://doi.org/10.1093/brain/awm204openalex-snapshot
Long-term survival with glioblastoma multiforme
inferredcites →https://doi.org/10.1093/neuonc/nos273openalex-snapshot
Standards of care for treatment of recurrent glioblastoma—are we there yet?
inferredcites →https://doi.org/10.1097/cad.0b013e3283161012openalex-snapshot
Hypertension and proteinuria: a class-effect of antiangiogenic therapies
inferredcites →https://doi.org/10.1111/j.1365-2354.2008.00956.xopenalex-snapshot
Outcome evaluation in glioblastoma patients using different ranking scores: KPS, GOS, mRS and MRC
inferredcites →https://doi.org/10.1200/jco.2007.12.2440openalex-snapshot
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
inferredcites →https://doi.org/10.1200/jco.2008.16.1612openalex-snapshot
Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
inferredcites →https://doi.org/10.1200/jco.2008.19.8721openalex-snapshot
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
inferredcites →https://doi.org/10.1200/jco.2009.26.3541openalex-snapshot
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
inferredcites →https://doi.org/10.1200/jco.2010.28.15_suppl.e13580openalex-snapshot
Hypertension (HTN) and proteinuria (PTN) as biomarkers of efficacy in antiangiogenic therapy for metastatic colorectal cancer (mCRC).
inferredcites →https://doi.org/10.1200/jco.2013.49.5283openalex-snapshot
Challenges of Guarantee-Time Bias
inferredcites →https://doi.org/10.1215/15228517-2007-038openalex-snapshot
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma
inferredcites →https://doi.org/10.1634/theoncologist.2009-0121openalex-snapshot
FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme
inferredcites →https://doi.org/10.2174/157488408784293705openalex-snapshot
The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
inferredcites →https://doi.org/10.3171/jns.1999.90.6.1072openalex-snapshot
Hormonal effects on glioblastoma multiforme in the nude rat model
inferredcites →https://doi.org/10.3171/jns.2001.95.2.0190openalex-snapshot
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
inferredcites →https://doi.org/10.3171/jns.2004.101.2.0219openalex-snapshot
The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4788499openalex-extracted
Integrated Analysis of VEGF and VEGFR Inhibitor-Induced Hypertension: Insights from Pharmacovigilance, Clinical Data, and Animal Models
inferred← citeshttps://doi.org/10.2139/ssrn.4804332openalex-extracted
Integrated Analysis of VEGF and VEGFR Inhibitor-Induced Hypertension: Insights from Pharmacovigilance, Clinical Data, and Animal Models
inferred← citeshttps://doi.org/10.1007/s10143-025-04088-7openalex-snapshot
Drug-induced hypertension is associated with improved survival in glioblastoma patients treated with bevacizumab: evidence from a time-to-event meta-analysis and meta-regression
inferred← citeshttps://doi.org/10.1007/s11060-025-05209-4openalex-snapshot
Prognostic value of hypertension timing for survival in glioblastoma patients receiving bevacizumab: a retrospective single centre analysis
inferred← citeshttps://doi.org/10.1007/s12672-024-00944-yopenalex-snapshot
A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy
inferred← citeshttps://doi.org/10.1016/j.clineuro.2020.105976openalex-snapshot
Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment
inferred← citeshttps://doi.org/10.1038/s41416-024-02602-0openalex-snapshot
Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICE
inferred← citeshttps://doi.org/10.1161/hypertensionaha.123.21119openalex-snapshot
Bevacizumab-Induced Hypertension in Glioblastoma Patients and Its Potential as a Modulator of Treatment Response
inferred← citeshttps://doi.org/10.1161/hypertensionaha.124.24523openalex-snapshot
CTRH as Biomarker of Drug Efficacy: In-Depth Assessment of Real-World Evidence
inferred← citeshttps://doi.org/10.1177/1078155220920684openalex-snapshot
Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1488853openalex-snapshot
Comprehensive analysis of VEGF/VEGFR inhibitor-induced immune-mediated hypertension: integrating pharmacovigilance, clinical data, and preclinical models
inferred← citeshttps://doi.org/10.3390/cells10071783openalex-snapshot
Sex-Specific Differences in Glioblastoma
inferred← citeshttps://doi.org/10.3892/mmr.2018.9411openalex-snapshot
Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
inferred← citeshttps://doi.org/10.4103/crst.crst_250_23openalex-snapshot
Glioblastoma multiforme - a rare type of cancer: A narrative review
inferred← citeshttps://doi.org/10.7759/cureus.29269openalex-snapshot
Bevacizumab-Induced Hypertension as a Potential Physiological Clinical Biomarker for Improved Outcomes in Patients With Recurrent Glioblastoma Multiforme: A Systematic Review
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.